H NMR and
13 C NMR were acquired on Varian 300/400 MHz NMR spectrometer. ESI-MS was collected on Finnigan LCQ TM DUO LC/MS spectrometer. MALDI-TOF spectrum was recorded on an ABI-MDS SCIEX 4800 MALDI-TOF/TOF mass spectrometer. The DLS size and zeta potential was collected on a Malvern Zetasizer nano S. Transmission electron microscopy (TEM) was performed on a Topcon 002B electron microscope at 200 kV. Sample preparation was carried out by placing a drop of the freshly prepared colloidal solution on a carbon-coated copper grid and allowing the solution to evaporate.
Upconversion luminescent/fluorescence imaging of Hela cell were performed on a Olympus IX83 inverted motorized microscope adapted with an additional external NIR laser with a wavelength at 980 nm as excitation light source (CNI high power fiber coupled diode laser system, FC-W-980, output power is set at 1W).
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Figure S1
. Synthesis of TDPA-Zn 2+ /Cu 2+ -UCNP@MSNs. Figure S2 . TEM (A) and DLS (B) size distribution of core, core-shell UCNP and metallic complex (TDPA-Zn 2+ ) functionalized UCNP@MSN. TEM size distribution was counted based on 100 nanoparticles. The DLS size distribution was collected based on the dispersion of 2 wt% UCNP nanoparticles in hexane (B up, UCNP core; middle, UCNP core-shell), and 5 wt% UCNP@MSNs in aqueous solution (B bottom). Figure S3 . FTIR spectra characterizations of the UCNP@MSNs, TDPA-UCNP@MSNs and 
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Conjugation of small functional molecules to polypeptide
The branched polypeptide G2d has abundant terminal amino groups (-NH 2 ) which can be used for further modification of polypeptide with functional molecules, such as targeting ligand folic acid (FA) and fluorescence dye TRITC. These amino groups can also been utilized to developed a fluorescamine based fluorescence assay for the calculation of the mean molecular weight and component ratio of the polypeptide. More details see below discussion.
(1) Labeling the polypeptide G2d with folic acid (FA), FA-G2d
To a 10 mL dry DMF in ice bath was added 44 mg of folic acid, 2 mg of DMAP, 12 mg of NHS and 20 mg of EDC·HCl. The solution was stirred at 0 o C for 30 min then was recovered to room temperature and stirred for another 3 h. Thereafter 200 mg of G2d was added and the mixture was further stirred overnight. After that, 20 mL acetone was added to precipitate the polypeptide. The polypeptide was collected by centrifugation and washed 3 times with methanol. After dried in vacuum, the FA-G2d was obtained as a slight yellow solid and characterized by UV-vis absorption spectrum, which showed the characteristic absorption peak of FA at 290 nm.
(2) Labeling the polypeptide G2d with TRITC TRITC labeled polypeptide G2d was prepared by the conjugation of TRITC to the terminal NH 2 on polypeptide branches. Typically, to a 10 mL dry DMF solution was added of 1 mg of TRITC and 100 mg of G2d. The mixture was stirred overnight. After that, 20 mL acetone was added to precipitate the polypeptide. The polypeptide was collected by centrifugation and washed 3 times with methanol. After dried in vacuum, the TRITC-G2d was obtained as a slight pink solid and characterized by fluorescence emission spectrum, which showed the characteristic emission of TRITC at 570 nm.
Measurement of mean molecular weight (Mw) and calculation of the component ratio of the block polypeptide through fluorimetry combined with 1H-NMR analysis
The polypeptide G1 contains 3 main backbones and each backbone consist of x molecule of Asp and y molecule of Lys. The ratio of Asp to Lys (x : y) in G1 can be calculated via 1H-NMR analysis (See Figure   S13 for an example). The signal at 1.25-1.78 ppm is due to the β, γ and δ-CH 2 for Lys (6H), while the signal at 4.65 ppm is due to the CH of Asp (1H). Thus using the integration area of these two peaks, the ratio x : y can be calculated. However, due the overlap with the solvent (DMSO-d 6 , δ 2.54 ppm) and water (δ 3.2 ppm), the signal for CH 2 in TAEA cannot be isolated, so the number of Asp and Lys cannot be quantified by using 1H-NMR.
the mean molecular weight (M w ) of the synthetic polypeptide. Fluorescamine is a commercial and widely used chemical reagent for bioanalysis. Fluorescamine is non-fluorescent but its fluorescence can be turned on once it reacts with a primary amine group (-NH 2 ), as shown below.
Thus the amount of amine group in the synthetic polypeptide can be quantified by using fluorescamine via fluorimetry.
(
1) Measurement of the mean molecular weight of polypeptide G1, M w (G1)
Polypeptide G1 is tri-branched and there is a terminal NH 2 group in each branch, so each G1 has 3 NH 2 groups. Thus
where n G1 is the molar amount of m G1 (g, weight) of polypeptide G1 and n G1 (NH 2 ) is the molar amount of NH 2 in polypeptide G1, which can be determinate by using fluorescamine via fluorimetry. Based on it, the M w (G1) can be calculated by:
(2) Measurement of the mean molecular weight of polypeptide core, M w (Gc)
The M w (Gc) can be directly achieved by the weight of polypeptide after deprotection of G1. For example, m 1 g of polypeptide G1 was introduced to the HBr/CH 3 COOH solution for removing the carbobenzyloxy protecting group (Cbz) on ε-NH 2 groups in Lys. Thereafter, m 2 g of polypeptide core was recovered. The yield of the deprotection was assumed to be 100%, so there will be
n Gc is the molar amount of polypeptide core.
The M w (Gc) can be calculated by:
(3) Calculation of the monomer ratio of Asp to Lys (x : y) in polypeptide G1
We can also calculate the Lys amount and the monomer ratio of Asp to Lys (x : y) in G1 and Gc based on above information. The weight loss between M w (Gc) and M w (G1) is due to the removal of Cbz group from Lys. Removal of 1 mol Cbz group will induce a weight loss of 134 g. Thus, the number of Lys in the backbone of polypeptide G1 (y) can be calculated by:
Each G1 is consist of 1 molecule of Tris(2-aminoethyl)amine (TAEA), 3x molecule of Asp(OBzl) residue and 3y molecule of Lys(Cbz) residue, the M w (G1) can also be calculated by: By using the value of M w (G1) obtained in eq. 2, and y obtained in eq. 4, the number of Asp in each backbone of G1 (x) can be obtained from eq. 7.
(4) Measurement of the mean molecular weight of polypeptide G2, M w (G2)
Each polypeptide G2 has two types of terminal NH 2 , the 3 NH 2 on the tri-branched main backbone and 3y NH 2 in the side chains which initiated by Lys residues. So using the similar method for calculating M w (G1), here we will have
Where m G2 is the weight of G2 and n G2 (NH 2 ) is the amount of NH 2 in G2 which can be obtained via fluorescamine based fluorescence assay.
(5) Measurement of the mean molecular weight of polypeptide G2d, M w (G2d)
Similar to the measurement of M w (Gc), the M w (G2d) can be directly achieved by the weight of polypeptide after deprotection of G2. For example, m 1 g of polypeptide G2 was introduced to remove the benzyl protecting group (OBzl) on D-COOH groups in Asp. After that, m 2 g of final polypeptide was recovered. The M w (G2d) can be calculated by:
n G2d is the molar amount of polypeptide G2d. As the yield of the deprotection can be achieved at 100%, which can be confirmed by 1H-NMR spectrum where the characteristic signal OBzl group (δ 7.2ppm, 5.1 ppm) disappear after de-protection. Thus there will be
thus, Thus the total number of Asp in G2d can be calculated by: (12) with the x obtained from eq. 7, and the y obtained from eq. 5., the Asp amount in each side chain (z) can be obtained by using eq. 12.
Four polypeptide G2di (i = 1, 2, 3 and 4) were prepared in this project and the main calculations are listed in Table 1 .
Calculation of drug loading amount of the UCNP@MSN
The loading efficiency of drugs loaded into the pores of UCNP@MSNs can be measured by the following method. To measure the loading efficiency, TDPA-Zn 2+ -UCNP@MSNs (a mg) and drug (b mg) were dispersed in 5 mL pH7.4 HEPES solution and stirred at room temperature for 2 h. Then the nanoparticles were collected by centrifugation (supernatant also was collected) and were re-dispersed into a HEPES solution of polypeptide (G2di) with sonication. The drug-loaded nanoparticles were isolated by centrifugation and was washed with pH7.4 HEPES. The supernatants were combined and the amount of unloaded drug was determined to be c mg by UV-vis absorption spectrum. Thus the amount of drug loaded into the pores of UCNP@MSN can be calculated by (b-c) mg drug / a mg of particle. The solvent using for loading CPT is methanol.
Based on this approach, the fluorescein loading amount using our UCNP@MSN with a total size of 54 nm and a thickness of 12 nm MSN shell was calculated to be 13.2 mg fluorescein /g of UCNP@MSN.
And the loading amounts for DOX and CPT was calculated to be 27.6 mg DOX/ g of UCNP@MSN and
19.5 mg CPT/ g of UCNP@MSN.
Calculation of the number of drug loaded in single UCNP@MSNs
We assumed the UCNP@MSN used in this work has spherical structure and has a UCNP core with diameter of 30 nm and a MSN shell with thickness of 12 nm. The density (d) for hexagonal NaYF4 is 4.2 g/cm 3 , and for MSN is around 0.9 g/cm 3 . Thus a single UCNP@MSN in this work will have a weight of S12 * Nanoparticles were dispersed in aqueous solution for DLS size distribution (number) and ζ potential measurement. Figure S7 . Release profiles of fluorescein (a) and surface bond polypeptide (b).
S15
NOTE:
The rapid release curve shows that polypeptide release precedes the release of the fluorescein.
These results further demonstrate that the triggered release of fluorescein is due to uncapping entrances by ATP through the replacement of polypeptide on outer surface of TDPA-Zn 2+ -UCNP@MSNs. 
